Sarah E Barnett

5PUBLICATIONS
44CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical mycologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 06, 2026
SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma.

Brian M Ortmann, Tekle Pauzaite, James A C Bertlin

|Jun 26, 2025
Methodology for generating chorioallantoic membrane patient-derived xenograft (CAM-PDX) models of pleural mesothelioma and performing preclinical imaging for the translation of cancer studies and drug screening.

Jan Schulze, Sarah Barnett, Liam Shaw

|Aug 20, 2024
Volatile organic compound analysis of malignant pleural mesothelioma chorioallantoic membrane xenografts.

Liam D Little, Sarah E Barnett, Theo Issitt

|Jan 20, 2023
BAP1 Loss Is Associated with Higher ASS1 Expression in Epithelioid Mesothelioma: Implications for Therapeutic Stratification.

Sarah E Barnett, Jenna Kenyani, Martina Tripari

|Dec 11, 2022
The Chick Embryo Xenograft Model for Malignant Pleural Mesothelioma: A Cost and Time Efficient 3Rs Model for Drug Target Evaluation.

Sarah E Barnett, Anne Herrmann, Liam Shaw

Pageof 1

Frequent Collaborators

5 joint publications

Judy M Coulson

2 joint publications

Joseph J Sacco

1 joint publications

Michael Shackcloth

1 joint publications

Elisabeth N Gash